Cue Biopharma, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $27.1M | $22.5M | $48.5M | $51.6M | $64.4M | $74.9M | $44.3M | $20.8M |
| Accounts Receivable | $5.5M | $945.0K | $1.7M | $57.0K | $3.1M | $1.4M | $754.9K | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $37.0M | $25.1M | $51.5M | $77.2M | $68.5M | $87.5M | $61.0M | $40.6M |
| Property, Plant & Equipment | $241.0K | $471.0K | $795.0K | $1.5M | $2.1M | $2.1M | $1.8M | $2.8M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $42.2M | $32.2M | $61.5M | $91.3M | $83.4M | $99.5M | $71.6M | $45.4M |
| Liabilities | ||||||||
| Accounts Payable | $3.9M | $2.8M | $3.5M | $2.7M | $2.6M | $2.1M | $882.7K | $2.0M |
| Total Current Liabilities | $13.5M | $13.7M | $17.1M | $11.5M | $12.8M | $16.3M | $11.7M | $6.2M |
| Long-Term Debt | — | $0 | $4.2M | $8.0M | $0 | — | — | — |
| Total Liabilities | $15.8M | $14.7M | $24.4M | $25.6M | $17.9M | $20.6M | $17.0M | $11.4M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-368.5M | $-341.9M | $-301.2M | $-250.5M | $-197.4M | $-153.3M | $-108.5M | $-71.8M |
| Total Stockholders' Equity | $26.4M | $17.5M | $37.1M | $65.7M | $65.5M | $78.9M | $54.6M | $34.0M |